According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled Trial (RCT) with crossover design
In adults diagnosed with hypertension, participants receive daily dietary nitrate supplementation (e.g., beetroot juice or sodium nitrate) for 2–4 weeks, followed by a washout period, then placebo (nitrate-free) for an equivalent duration. Plasma nitrite and cGMP levels are measured at baseline, end of each phase, and blood pressure is tracked. The comparison of nitrate vs. placebo phases within the same individuals isolates the effect of nitrate on biomarkers and confirms pathway activation. Parallel-group RCT with biomarker focus
Two groups of adults with hypertension are randomized to either daily nitrate supplementation or placebo for 4–6 weeks. Plasma nitrite and cGMP are measured at baseline and endpoint. A statistically significant 2.7-fold increase in nitrite and 1.4-fold increase in cGMP in the nitrate group versus placebo, alongside a corresponding drop in BP, would support the claim’s quantitative and mechanistic assertions. Mechanistic biomarker study with pharmacokinetic profiling
In adults with hypertension, plasma nitrite and cGMP are measured at multiple time points (e.g., 0, 1, 2, 4, 6, 8, 24 hours) after a single dose of dietary nitrate. A temporal correlation between nitrate ingestion → nitrite peak → cGMP rise → BP drop would provide direct evidence of the nitrate-nitrite-NO pathway activation as the mechanism. Dose-response study with biomarker thresholds
Multiple groups of adults with hypertension receive escalating daily doses of dietary nitrate (e.g., 0, 3.2, 6.4, 9.6 mmol) for 2 weeks. If plasma nitrite and cGMP levels rise proportionally with dose and correlate with BP reduction, this supports the claim’s quantitative assertions (2.7-fold and 1.4-fold) and mechanistic link. Observational cohort with biomarker tracking
Adults with hypertension who self-select into high-nitrate diet vs. low-nitrate diet are followed for 8 weeks. Plasma nitrite and cGMP are measured at baseline and endpoint. A consistent 2.7-fold and 1.4-fold increase in the high-nitrate group, alongside greater BP reduction, would support the claim in a real-world context.